- Sanofi and NIHR enrol first patient in immunisation study for RSV in infants
- NHS England outlines measures to boost capacity ahead of substantial winter pressures
- Focused ultrasound therapies could be made more affordable by 3D-printed acoustic holograms to help overcome the blood-brain barrier
- Cognitive rehabilitation therapy may help older adults clear COVID-19-related brain fog
- MHRA grants marketing authorisation for Novartis’ Pluvicto
- Bristol Myers Squibb and GentiBio in $1.9bn deal to develop inflammatory bowel disease therapies
- Blood tests taken within 24 hours of a traumatic brain injury can predict whether a patient will die, or survive with serious disability
- ONS figures show rapid decrease in people with higher COVID-19 antibody figures
- Pfizer to buy Global Blood Therapeutics for $5.4bn
- All children aged one to nine in London to be offered polio vaccine
- NHS backlog of 22,500 longest-wait patients slashed to fewer than 200, says NHS England figures
- COVID-19 sewage surveillance labs join the hunt for monkeypox
- Study highlights major factors in shaping cross-disorder cortical abnormalities
- Survey reveals 45% of junior doctors are considering leaving the profession
- Karuna Therapeutics announces positive results from Phase III trial into schizophrenia